Tag: Insulin
Exacerbations Down in Asthma Patients on GLP-1R Agonists for T2D
Lower exacerbation counts, fewer health care encounters for asthma symptoms seen in asthma patients with T2D initiating GLP-1R agonists
Once-Weekly Insulin Icodec Promising for Type 2 Diabetes
Icodec results in greater increase in time-in-range versus once-daily insulin glargine U100 in two phase 2 randomized, open-label trials
Mortality Higher for Diabetic Ketoacidosis With COVID-19
Obesity, higher insulin requirements may be associated with higher mortality
Former Anabolic Steroid Users Have Impaired Testicular Function
In former users, longer accumulated duration of anabolic androgenic steroid use was associated with lower serum INSL3
Childhood Insulin Levels Linked to Later Psychosis Risk
Additionally, major increase in body mass index during puberty tied to increased risk for depression as young adult
Appetite-Regulating Hormones Lower After Sucrose Versus Glucose
Increases in glucose, insulin, GLP-1, PYY less robust with sucrose versus glucose ingestion; increases in glucose, PYY smaller in obese adults
Disparities in Insulin Pump Use Persist, 2005 to 2019
Use higher among White children with type 1 diabetes versus Black and Hispanic children
Manufacturer Prices for Insulin Substantially Higher in the U.S.
Manufacturer prices more than eight times higher in the U.S. than in other high-income countries
Once-Weekly Insulin Icodec Promising for Type 2 Diabetes
In phase 2 study, glucose-lowering efficacy, safety profile similar to once-daily insulin glargine U100
Closed-Loop System Beneficial for Children With T1DM
Glucose level within target range for greater percentage of time than with sensor-augmented insulin pump
